Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase NA 1Phase 2 1

Status

Completed 6

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 5Genitourinary 2

Conditions

Parathyroid Neoplasms 3Hyperparathyroidism, Primary 3Hyperparathyroidism 3Neoplasm Metastasis 2Prostatic Neoplasms 1Osteoporosis 1Hyperparathyroidism, Secondary 1Hypercalcemia 1Chronic Kidney Disease-Mineral and Bone Disorder 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Interventional × Cinacalcet × Clear all
NCT03123406 2024-04-29

ACTIVE

Kyowa Kirin Co., Ltd.

Phase 4 Completed
750 enrolled
GenitourinaryHead & Neck

Hyperparathyroidism, Hyperparathyroidism, Secondary, Neoplasm Metastasis, Chronic Kidney Disease-Mineral and Bone Disorder

NCT03027557 2021-05-25

DENOCINA

Aalborg University Hospital

Phase 3 Completed
46 enrolled 49 charts
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT04637360 2020-11-19

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Min-Sheng General Hospital

Phase NA Completed
40 enrolled
Head & Neck

Hyperparathyroidism, Neoplasm Metastasis, Osteoporosis

NCT01054079 2018-07-05

Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer

Wake Forest University Health Sciences

Phase 2 Completed
20 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

NCT01460030 2017-03-03

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Kyowa Kirin Co., Ltd.

Phase 3 Completed
Head & Neck

Hypercalcemia, Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT00037518 2013-05-08

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Amgen

Phase 4 Completed
46 enrolled
Head & Neck

Hyperparathyroidism, Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡